NIR-triggered and Thermoresponsive Core-shell nanoparticles for synergistic anticancer therapy

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Conventional cancer monotherapies are often insufficient for complex tumors.
• Synergistic therapeutic approaches are needed for personalized and effective cancer treatment.
• Combining photothermal therapy (PTT) and chemotherapy offers a promising strategy for tumor management.

Purpose of the Study:

• To develop a novel thermoresponsive mesoporous silica nanoparticle (MSN) system for co-delivery of doxorubicin and photothermal agents.
• To investigate the synergistic anti-tumor efficacy of the combined PTT and chemotherapy approach.
• To evaluate the controlled drug release and biocompatibility of the developed nanoplatform.

Main Methods:

• Synthesis of MSN loaded with doxorubicin and copper sulfide (CuS) nanoparticles.
• Integration of an upper critical solution temperature (UCST) polymer for thermoresponsive drug release.
• In vitro evaluation using 4T1 mouse breast carcinoma cells.
• In vivo studies using a 4T1 tumor-bearing mouse model.

Main Results:

• The developed nanomaterial demonstrated efficient photothermal conversion and controlled doxorubicin release.
• Synergistic anti-tumor effects were observed in both in vitro and in vivo experiments.
• The combined therapy significantly enhanced anti-tumor efficacy compared to monotherapies.
• Minimal collateral damage to healthy tissues was noted.

Conclusions:

• The UCST-responsive nanoplatform effectively combines PTT and chemotherapy for enhanced cancer treatment.
• This innovative approach offers a potential strategy for personalized cancer therapy with improved efficacy and reduced side effects.
• The nanoplatform exhibits high stability, biocompatibility, and significant potential for clinical applications.